Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Boyd

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Factors influencing the cellular accumulation of SN-38 and camptothecinJeffrey Cummings, Gary Boyd, Janet S Macpherson, et al.
Biochemical Pharmacology|May 7, 2002
Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidationJeffrey Cummings, Gary Boyd, Brian T Ethell, et al.
Cancer Research|December 18, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additivesJeffrey Cummings, Brian T Ethell, Lesley Jardine, et al.
Biochemical Pharmacology|December 12, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteinsJeffrey Cummings, Noam Zelcer, John D Allen, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cancer Chemotherapy and Pharmacology|April 6, 2002
Factors influencing the cellular accumulation of SN-38 and camptothecinJeffrey Cummings, Gary Boyd, Janet S Macpherson, et al.
Biochemical Pharmacology|May 7, 2002
Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidationJeffrey Cummings, Gary Boyd, Brian T Ethell, et al.
Cancer Research|December 18, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additivesJeffrey Cummings, Brian T Ethell, Lesley Jardine, et al.
Biochemical Pharmacology|December 12, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteinsJeffrey Cummings, Noam Zelcer, John D Allen, et al.
Pageof 5